ADTX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 109430 min ago

@ $4.00

Wydano: 13 vas. 2024 @ 21:29

Zwrot: -38.00%

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 21:23):

Stats
Dzisiejszy wolumen	24 709.00
Średni wolumen	377 664
Kapitalizacja rynkowa	4.86M
EPS	$0 ( 2024-04-02 )
Następna data zysków	( $-3.33 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0200
ATR14	$0.0410 (1.65%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-08	Runge Jeffrey W.	Buy	470	Options (right to buy)
2023-11-08	Albanna Rowena	Buy	4 702	Options (right to buy)
2023-11-08	Nelson Charles Athle	Buy	470	Options (right to buy)
2023-11-08	Albanna Amro A.	Buy	9 404	Options (right to buy)
2023-11-08	Pankovcin Corinne	Buy	4 702	Options (right to buy)

INSIDER POWER
26.53
Last 84 transactions
Buy: 1 934 500 \| Sell: 1 185 103

Wolumen Korelacja

Długi: 0.02 (neutral)

Krótki: -0.31 (neutral)

Signal:(52.983) Neutral

ADiTx Therapeutics, Inc. Korelacja

10 Najbardziej pozytywne korelacje
OGI	0.974
BNGO	0.971
VERB	0.971
CNXC	0.968
IMBI	0.965
NESR	0.965
MRIN	0.964
WATT	0.963
MMAT	0.962
DISH	0.961

10 Najbardziej negatywne korelacje
MSDA	-0.971
ADAL	-0.966
TIOAU	-0.961
TIOA	-0.961
BRIV	-0.96
LEGA	-0.959
ZING	-0.959
SKYA	-0.958
CRZN	-0.957
VLAT	-0.957

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ADiTx Therapeutics, Inc. Korelacja - Waluta/Towar

-0.58
( weak negative )

0.00
( neutral )

-0.58
( weak negative )

0.63
( weak )

0.61
( weak )

ADiTx Therapeutics, Inc. Finanse

Annual	2023
Przychody:	$645 176
Zysk brutto:	$-654 243 (-101.41 %)
EPS:	$-107.10

FY	2023
Przychody:	$645 176
Zysk brutto:	$-654 243 (-101.41 %)
EPS:	$-107.10

FY	2022
Przychody:	$933 715
Zysk brutto:	$166 936 (17.88 %)
EPS:	$-608.04

FY	2021
Przychody:	$105 034
Zysk brutto:	$27 055.00 (25.76 %)
EPS:	$-6.72

Financial Reports:

No articles found.

ADiTx Therapeutics, Inc.

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.